Gene targeting for chylomicronemia syndrome: The brave new world

Atherosclerosis. 2018 Feb:269:254-255. doi: 10.1016/j.atherosclerosis.2017.12.017. Epub 2017 Dec 19.

Authors

Federica Fogacci¹, Arrigo F G Cicero²

Affiliations

¹ Atherosclerosis and Metabolic Disease Research Unit, Medical and Surgical Sciences Department, University of Bologna, Bologna, Italy. Electronic address: federica.fogacci@studio.unibo.it.
² Atherosclerosis and Metabolic Disease Research Unit, Medical and Surgical Sciences Department, University of Bologna, Bologna, Italy.

PMID: 29277440
DOI: 10.1016/j.atherosclerosis.2017.12.017

No abstract available

Keywords: Familial chylomicronemia syndrome; Gene therapy; Hyperchylomicronemia; Lipoprotein lipase deficiency.

Publication types

Editorial
Comment

MeSH terms

Gene Targeting*
Humans
Hyperlipoproteinemia Type I*